2-Deoxyglucose and Newcastle Disease Virus Synergize to Kill Breast Cancer Cells by Inhibition of Glycolysis Pathway Through Glyceraldehyde3-Phosphate Downregulation
/in Breast Cancer, International Publications, Newcastle Disease Virus /von 2019-09-27 / Front Mol Biosci 2019;6:90Blockade of PD-L1 Enhances Cancer Immunotherapy by Regulating Dendritic Cell Maturation and Macrophage Polarization
/in Checkpoint-Inhibitors, Dendritic Cells, International Publications /von 2019-09-19 / Cancers (Basel) 2019 Sep;11(9)Dendritic Cell-Based and Other Vaccination Strategies for Pediatric Cancer
/in Brain Tumors in Children, Dendritic Cells, International Publications /von 2019-09-19 / Cancers (Basel) 2019 Sep;11(9)Past, Current, and Future of Immunotherapies for Prostate Cancer
/in Checkpoint-Inhibitors, Dendritic Cells, International Publications, Newcastle Disease Virus, Prostate Cancer /von 2019-09-11 / Front Oncol 2019;9:884The current state of immunotherapy for gliomas: an eye toward the future
/in Dendritic Cells, Glioblastoma, International Publications, Newcastle Disease Virus /von 2019-09-01 / J. Neurosurg. 2019 09;131(3):657-666Phase I/II clinical trial of modulated electro-hyperthermia treatment in patients with relapsed, refractory or progressive heavily treated ovarian cancer
/in Hyperthermia, International Publications, Ovarian Cancer /von 2019-09-01 / Jpn. J. Clin. Oncol. 2019 Sep;49(9):832-838
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de